Diverse JAK2 exon 12 mutations have been described in patients with V617F-negative polycythemia vera. Development of a sensitive detection assay capable of identifying any of these mutations is required for medium-throughput diagnostic screens. Non-mutated and mutant JAK2 exon 12 alleles were amplified from patient samples and cloned into plasmid vectors, then used to determine the sensitivity of a novel high-resolution melting-curve assay designed to detect all mutant JAK2 exon 12 alleles tested. High resolution melting analysis was more sensitive than direct sequencing and capable of detecting exon 12 mutations in granulocytes at moderate levels. In a blinded analysis of DNAs from V617F-negative erythrocytosis patients, with direct sequen...
Background/PurposeThe activating JAK2 mutation with a G-C to T-A transversion at codon 617 (JAK2V617...
<p>A: Sequence of F537-I540delinsLV mutation of PV4 revealing a 10 base-pair deletion and a four bas...
Detection of the JAK2V617F mutation is essential for diagnosing patients with classical myeloprolife...
Diverse JAK2 exon 12 mutations have been described in patients with V617F-negative polycythemia vera...
gene have been described in 5 to 10% of the patients with erythrocytosis. According to the updated ...
BACKGROUND: Myeloproliferative disorders are characterized by clonal expansion of normal mature bloo...
BACKGROUND: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and...
Background: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and...
The screening for JAK2 V617F mutation in patients with polycythemia vera, essential thrombocythemia,...
The JAK2V617F point mutation has been described in 65 to 97% of patients with polycythemia vera (PV)...
<div><p>Mutations in the <em>Janus kinase 2</em> (<em>JAK2</em>) gene have become an important ident...
Текст статьи не публикуется в открытом доступе в соответствии с политикой журнала.Background: Somati...
Background: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and...
The activating JAK2 mutation with a G-C to T-A transversion at codon 617 (JAK2V617F) is associated w...
The diagnosis of polycythemia vera (PV) requires the integration of clinical and laboratory findings...
Background/PurposeThe activating JAK2 mutation with a G-C to T-A transversion at codon 617 (JAK2V617...
<p>A: Sequence of F537-I540delinsLV mutation of PV4 revealing a 10 base-pair deletion and a four bas...
Detection of the JAK2V617F mutation is essential for diagnosing patients with classical myeloprolife...
Diverse JAK2 exon 12 mutations have been described in patients with V617F-negative polycythemia vera...
gene have been described in 5 to 10% of the patients with erythrocytosis. According to the updated ...
BACKGROUND: Myeloproliferative disorders are characterized by clonal expansion of normal mature bloo...
BACKGROUND: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and...
Background: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and...
The screening for JAK2 V617F mutation in patients with polycythemia vera, essential thrombocythemia,...
The JAK2V617F point mutation has been described in 65 to 97% of patients with polycythemia vera (PV)...
<div><p>Mutations in the <em>Janus kinase 2</em> (<em>JAK2</em>) gene have become an important ident...
Текст статьи не публикуется в открытом доступе в соответствии с политикой журнала.Background: Somati...
Background: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and...
The activating JAK2 mutation with a G-C to T-A transversion at codon 617 (JAK2V617F) is associated w...
The diagnosis of polycythemia vera (PV) requires the integration of clinical and laboratory findings...
Background/PurposeThe activating JAK2 mutation with a G-C to T-A transversion at codon 617 (JAK2V617...
<p>A: Sequence of F537-I540delinsLV mutation of PV4 revealing a 10 base-pair deletion and a four bas...
Detection of the JAK2V617F mutation is essential for diagnosing patients with classical myeloprolife...